The Book Of GLP-1s: For Medtech They Giveth, As Well As Taketh Away

GLP-1 inhibitors for weight loss are rapidly threatening several medtech segments; however, in ensuring their long-term efficacy, digital health companies could benefit.

• Source: Shutterstock

More from Digital Technologies

More from Medtech Insight